Roche Holding AG – Enterprise Tech Ecosystem Series
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Roche joined forces with GE Healthcare to combine both companies’ capabilities and leverage big data, machine learning, genomics, and imaging technologies to develop decision support tools for clinicians, and help them take data-driven and personalized decisions at each stage of patients’ diseases.
In 2013, Roche and California Institute for Quantitative Biosciences (QB3) formed a strategic alliance to create a venture arm, Mission Bay Capital, in order to identify, support, and invest in early stage start-ups focusing on life science, and explore potential opportunities in emerging technologies.
In 2020, Roche launched a National Artificial Intelligence Centre of Excellence in Canada with the vision to launch AI-based solutions that optimize and shrink the cost of healthcare delivery and improve health outcomes.
In April 2020, Roche formed a Data Science Coalition platform to address the challenges posed by SARS-CoV-2 (COVID-19) pandemic.
The report provides information and insights into Roche’s tech activities, including –
– Insights of its digital transformation strategies and innovation programs
– Overview of technology initiatives covering partnerships, product launches, investments and acquisitions
– Insights on each technology initiative including technology theme, objective, and benefits
– Details of estimated ICT budgets and major ICT contracts
Scope
– Roche is tapping key disruptive technologies to reduce time-to-market capabilities, and develop innovative products that can help provide advanced healthcare solutions to patients, and improve customer engagement. Artificial intelligence, big data, biotechnology, blockchain, analytics, cloud, robotic process automation, 3D printing, mobile, and genomics are the key technologies under focus for the company.
– Roche is embarking on its digital transformation journey through innovations, research and development centers, and technology acquisitions, in order to bring innovative products and solutions for its customers.
– Roche Diagnostics collaborated with Microsoft and Cleidon to tap into IoT and cloud computing technologies, and transform their healthcare product and services portfolio related to in vitro diagnostic (IVD) devices, and to offer patients with better healthcare solutions.
– Roche has setup an global hub and created a big-data ecosystem equipped with necessary digital and IT infrastructure, which acts as a comprehensive diabetes management platform.
Reasons to Buy
– Gain insights into Roche’s tech operations.
– Gain insights into its tech strategies and innovation initiatives.
– Gain insights into its technology themes under focus.
– Gain insights into various product launches, partnerships, investments and acquisition strategies of Roche.
ZappRx
GE Healthcare
Alcyone Lifesciences
Organovo
Ocean Protocol
Aligos
Jasper Therapeutics
Black Diamond Therapeutics
Purigen Biosystems
MacuLogix
Minoryx Therapeutics
Ideaya Biosciences
NMD Pharma
Pandion Therapeutics
Vivet Therapeutics
Lumos Pharma
Mission Therapeutics
Biodesy
Viewics
Syapse
Omicia
Freenome
Second Genome
Flatiron Health
Carbon Health
Spark Therapeutics
Promedior
ForSight VISION4
mySugr
Diabeloop
Sensyne Health
Veeva Systems
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.